Figure 2From: Bioactive properties and clinical safety of a novel milk protein peptide Comparison of HT-29 human colon cancer cell death between commercially available whey peptides and the MP mixture. HT-29 colon cancer cells were incubated with 0.68 μg/μl concentration of commercial hydrolyzed whey protein, MP peptides, and vehicle only (control). Pictures were taken after 20 hours of incubation.Back to article page